The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
Viviane Ponath(Philipps University of Marburg), Elke Pogge von Strandmann(Philipps University of Marburg), Reem Al Khayer(Philipps University of Marburg), Miriam Frech, Andreas Neubauer(RWTH Aachen University), Cornelia Brendel(Philipps University of Marburg), Mathis Bittermann(Philipps University of Marburg)
Cited by 14
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573